The 2026 documentary You Can See Everything has emerged as a commercial powerhouse, detailing the final month Elizabeth Holmes spent in freedom before her prison sentencing. Co-directed by Nathan Fielder and Lance Oppenheim, the film has seen rapid growth in both theater count and revenue since its debut.
The 21.8% surge that broke A24's documentary records
A24 utilized a calculated release strategy for You Can See Everything, starting the film in 855 U.S. theaters where it earned $15.6 million during its opening weekend. While it placed second behind the film Street Fighter, the documentary's momentum accelerated quickly. As reported by Deadline, the film expanded to 1,800 theaters by its second weekend, contributing to a week-on-week increase of 21.8%.
This growth represents the strongest second-week performance for any A24 release that launched in 600 or more theaters. According to the source, this trajectory differs from the 2025 film Marty Supreme, which saw a massive 1,730.3% jump because it began in a far more limited rollout of only six theaters. Because You Can See Everything started with a wider footprint, its 21.8% rise is viewed by analysts as a more significant indicator of sustained audience demand for non-fiction content.
A $7 million investment chasing a $100 million milestone
The financial efficiency of You Can See Everything is striking, given its reported production cost of approximately $7 million. The film reached its break-even point—estimated between $17.5 million and $20 million—very early in its run. Currently, the documentary has amassed nearly $45 million in domestic earnings, positioning it to potentially cross the $100 million threshold.
If the film reaches that six-figure milestone, it would enter the top ten highest-grossing non-concert documentaries in U.S. history. Such a feat would see it surpass the 2009 film Earth, signaling a shift in how audiences conssume true-crime and corporate tragedy on the big screen. The commercial success is bolstered by critical acclaim, with the source noting a 98% rating from critics and a 97% audience score on Rotten Tomatoes.
Elizabeth Holmes as a cautionary symbol in 2026
The success of the film reflects a broader cultural fascination with the intersection of medical ethics and corporate fraud . By focusing on the intimate final days of Elizabeth Holmes, directors Nathan Fielder (known for The Rehearsal) and Lance Oppenheim (known for Ren Faire) have avoided the sensationalism typical of the genre. Instead, they provide a nuanced look at the human cost of the Theranos collapse.
This approach taps into a growing trend of "immersive storytelling" where investigative journalism is blended with cinematic intimacy. By framing Holmes not just as a fraudster but as a person facing the immediate reality of a five-year sentence, the filmmakers have turned a business failure into a character study that resonates with a wide domestic audience.
The identity of the paartner accompanying Elizabeth Holmes
Despite the film's transparency regarding Holmes' mindset , certain details remain vague in the reporting . The source mentions that the filmmakers spent time with Holmes and "the woman who has been her partner" throughout the events leading to her trial, yet this individual remains unnamed. It is unclear if this partner provides a corroborating account of Holmes' behavior or serves as a foil to her narrative.
Additionally, while the domestic numbers are clear, the report does not specify how the film is performing in international markets. given that the Theranos scandal was a global news event, the extent to which international audiences are driving the film's momentum remains an open question.
Comments 0